Impact of Neoadjuvant & Adjuvant Therapies on Oncologic Reconstructive Surgery Sat, Oct 22

Neoadjuvant and adjuvant therapies in cancer care continue to evolve, and new immunotherapy, hormonal, and chemotherapeutic are emergent. This panel will discuss the impact of these agents on wound healing and post-surgical outcome.

At the end of this activity participants will be able to:

  1. Obtain evidence-based knowledge regarding novel neoadjuvant and adjuvant cancer treatment agents.

  2. Understand the appropriate timing of reconstructive procedures including appropriate duration of cessation, and risk of wound healing complications

Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.

Designation: The ASPS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Subject to change